| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0001400 | Intron-Exon-Intron | chr16:68127259-68248335 | chr16:68093356-68214432 | 104 nt | 0.4712 |
| hsa_NFATC3_0000900 | Intron-Exon | chr16:68127259-68260462 | chr16:68093356-68226559 | 250 nt | 0.3800 |
| hsa_NFATC3_0001500 | Intron-Exon-Intron | chr16:68130210-68157024 | chr16:68096307-68123121 | 250 nt | 0.3080 |
| hsa_NFATC3_0001800 | Intron-Exon-Intron | chr16:68130210-68160513 | chr16:68096307-68126610 | 163 nt | 0.4479 |
| hsa_NFATC3_0001600 | Intron-Exon-Intron | chr16:68130210-68217269 | chr16:68096307-68183366 | 250 nt | 0.3040 |
| hsa_NFATC3_0001700 | Intron-Exon | chr16:68130210-68225678 | chr16:68096307-68191775 | 250 nt | 0.3200 |
| hsa_NFATC3_0002100 | Intron-Exon-Intron | chr16:68132225-68157024 | chr16:68098322-68123121 | 250 nt | 0.3960 |
| hsa_NFATC3_0002400 | Intron-Exon-Intron | chr16:68132225-68160513 | chr16:68098322-68126610 | 163 nt | 0.4479 |
| hsa_NFATC3_0002500 | Intron-Exon-Intron | chr16:68132225-68208417 | chr16:68098322-68174514 | 173 nt | 0.4162 |
| hsa_NFATC3_0002200 | Intron-Exon-Intron | chr16:68132225-68217269 | chr16:68098322-68183366 | 250 nt | 0.3920 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].